AngioDynamics, Inc. (NASDAQ:ANGO) Shares Bought by Northern Trust Corp

Northern Trust Corp grew its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 2.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 351,365 shares of the medical instruments supplier’s stock after buying an additional 8,260 shares during the quarter. Northern Trust Corp owned 0.87% of AngioDynamics worth $3,219,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of ANGO. SBI Securities Co. Ltd. acquired a new position in AngioDynamics in the 4th quarter worth about $28,000. Bank of New York Mellon Corp grew its position in shares of AngioDynamics by 3.2% in the fourth quarter. Bank of New York Mellon Corp now owns 122,676 shares of the medical instruments supplier’s stock valued at $1,124,000 after purchasing an additional 3,815 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in shares of AngioDynamics in the fourth quarter valued at approximately $879,000. Charles Schwab Investment Management Inc. grew its position in shares of AngioDynamics by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 329,090 shares of the medical instruments supplier’s stock valued at $3,014,000 after purchasing an additional 2,270 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of AngioDynamics by 46.0% in the fourth quarter. JPMorgan Chase & Co. now owns 807,483 shares of the medical instruments supplier’s stock valued at $7,397,000 after purchasing an additional 254,322 shares in the last quarter. Institutional investors and hedge funds own 89.43% of the company’s stock.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and issued a $16.00 price objective (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

AngioDynamics Stock Up 0.4%

ANGO opened at $9.45 on Friday. AngioDynamics, Inc. has a 52 week low of $5.47 and a 52 week high of $13.50. The business has a fifty day simple moving average of $9.47 and a 200-day simple moving average of $9.48. The firm has a market cap of $383.74 million, a P/E ratio of -1.68 and a beta of 0.58.

AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.16. The business had revenue of $72.00 million for the quarter, compared to analysts’ expectations of $70.30 million. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. AngioDynamics’s revenue was down 4.3% on a year-over-year basis. Sell-side analysts expect that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.